• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

Introduction to 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid (CAS No. 1029144-15-7)

5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid, identified by the chemical identifier CAS No. 1029144-15-7, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrrolopyrimidine class, a structural motif widely recognized for its biological activity and potential therapeutic applications. The pyrrolopyrimidine scaffold is particularly noteworthy due to its presence in numerous bioactive molecules, including several FDA-approved drugs that target various diseases such as cancer, inflammation, and infectious disorders.

The 4-carboxylic acid functional group in the molecular structure of 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid introduces a site for further chemical modification, enabling the synthesis of derivatives with tailored biological properties. This versatility makes it a valuable intermediate in drug discovery and development pipelines. Researchers have leveraged this compound to explore novel pharmacophores that interact with specific biological targets, leading to the identification of promising candidates for clinical trials.

Recent advancements in synthetic methodologies have enhanced the accessibility of 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid, facilitating its incorporation into more complex molecular architectures. For instance, transition-metal-catalyzed cross-coupling reactions and palladium-mediated transformations have been employed to introduce diverse substituents at the pyrrole and pyrimidine rings. These modifications have yielded derivatives with enhanced binding affinity and selectivity for therapeutic targets, such as kinases and transcription factors.

The pharmacological potential of 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid has been explored in several preclinical studies. Notably, derivatives of this compound have demonstrated inhibitory effects on enzymes implicated in cancer progression. For example, studies have shown that certain analogs can suppress the activity of tyrosine kinases, which are overexpressed in many solid tumors. Additionally, the compound has shown promise in modulating inflammatory pathways by interacting with receptors and enzymes involved in immune responses.

Another area of interest is the use of 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid in the development of antiviral agents. The structural features of this molecule allow it to mimic natural nucleobases, enabling it to interfere with viral replication processes. Researchers have synthesized analogs that exhibit inhibitory activity against RNA-dependent RNA polymerases, key enzymes in viral replication cycles. These findings highlight the compound's potential as a lead structure for antiviral drug development.

The synthesis of 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Common synthetic routes include cyclization reactions followed by functional group transformations such as carboxylation and decarboxylation. Advances in flow chemistry have also enabled more efficient production processes for this compound, reducing solvent consumption and improving scalability.

In conclusion, 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid (CAS No. 1029144-15-7) represents a structurally intriguing and biologically relevant molecule with significant therapeutic implications. Its role as a key intermediate in drug discovery underscores its importance in modern medicinal chemistry. As research continues to uncover new applications for this compound and its derivatives, it is likely to remain a cornerstone in the development of innovative treatments for various diseases.

• 79323-15-2(Pyrrolo[1,2-a]quinoxaline-4-carboxylic acid)
• 945840-82-4(1H-Pyrrolo[2,3-c]pyridine-7-carboxylic acid)
• 933696-52-7(2-methyl-1H-imidazo[4,5-c]pyridine-4-carboxylic acid)
• 933728-33-7(1H-Imidazo[4,5-c]pyridine-4-carboxylic acid)
• 1211590-38-3(3H-Imidazo[4,5-c]pyridine-6-carboxylic acid)
• 251102-27-9(Pyrrolo[1,2-c]pyrimidine-3-carboxylic acid)
• 26052-96-0(9H-pyrido3,4-bindole-1-carboxylic Acid)
• 138891-64-2(Imidazo[1,5-a]quinoline-3-carboxylic acid)
• 138891-51-7(Imidazo[1,5-A]pyridine-1-carboxylic acid)
• 17288-35-6(1H-Pyrrolo[3,2-b]pyridine-2-carboxylic acid)